Osaic Holdings’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Osaic Holdings's XENE Position: Q3 2026 in Review
Osaic Holdings increased its Xenon Pharmaceuticals (XENE) stake by 32% in Q3 2026, buying an estimated $6.3K and bringing the position to 438 shares worth $16.3K. The position accounts for ﹤0.01% of the portfolio, ranked #6327.
Osaic Holdings first reported a position in XENE in Q1 2020 and has held it in 27 quarters since. The position peaked at $133K in Q3 2023. 288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Osaic Holdings held 438 shares of Xenon Pharmaceuticals worth $16.3K as of Q3 2026.
- Osaic Holdings bought 106 Xenon Pharmaceuticals shares in Q3 2026, an estimated $6.3K.
- Xenon Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6327 holding.
- Osaic Holdings first reported a position in Xenon Pharmaceuticals in Q1 2020 and has held it in 27 quarters since.
- Osaic Holdings's Xenon Pharmaceuticals position peaked at $133K in Q3 2023.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.